Newsroom Investors Who We Are Businesses NASDAQ: NVOS Our People Governance NVOS's directors have adopted corporate governance principles aimed at ensuring that the Board is independent and fully informed on the key strategic and risk issues NVOS faces. Board of Directors (NVOS) Robert Mattacchione Board Chairman & CEO Michael Pope Chairman, Audit Committee Chris David COO/President Pierre Dalcourt Michael Gaynor Alex Flesias Chairman, Nominating & Corporate Governance Committee Robert Oliva Chairman, Compensation Committee Audit Committee Charter Michael Pope Chairman, Audit Committee Alex Flesias Chairman, Nominating & Corporate Governance Committee Robert Oliva Chairman, Compensation Committee Compensation Committee Charter Robert Oliva Chairman, Compensation Committee Alex Flesias Chairman, Nominating & Corporate Governance Committee Michael Gaynor Nominating & Corporate Governance Committee Charter Chris David COO/President Alex Flesias Chairman, Nominating & Corporate Governance Committee Robert Oliva Chairman, Compensation Committee Governance Documents NVOS's governance framework guides the Board and management’s oversight of the company and is outlined in its governing documents. The Certificate of Incorporation and By-Laws establish fundamental principles about NVOS's capital structure, shareowner rights and its directors and officers. The Governance Principles provide additional detail on Board operations and key governance policies. The NVOS Board has several standing committees, each of which has specified responsibilities that are set forth in its committee charter. Downloadable Content Code of Ethics Policy Audit Committee Charter Compensation Committee Charter Nominating & Corporate Governance Committee Charter Stay connected with Investor news Follow us and stay up to date on what's happening at Novo Integrated Sciences CAUTION CONCERNING FORWARD LOOKING STATEMENTS Novo Integrated Sciences's Investor Relations website at www.novointegrated.com/investors and our corporate blog at novointegrated.com/newsroom as well as Novo Integrated Sciences's social media accounts, contain a significant amount of information about the company, including financial and other information for investors. Novo Integrated Sciences encourages investors to visit these websites from time to time, as information is updated and new information is posted. ROBERT MATTACCHIONE CEO, Novo Integrated Sciences Inc Follow Robert on LinkedIn CHRIS DAVID President, Novo Integrated Sciences Inc Follow Chris on LinkedIn Subscribe for Company Updates Email* Submit Follow Us Company Novo Integrated Sciences is a U.S. based parent company, publicly-traded on the Nasdaq Capital Markets (Nasdaq:NVOS), with both U.S. and Canadian based wholly owned subsidiaries. Currently, the Company’s revenue is generated solely by services and products provided by NHL’s team of multidisciplinary primary care clinicians and practitioners in Canada. Site Map Investors About Newsroom SEC Reports Careers Contact Address 11120 NE 2nd Street, Suite 100 Bellevue, Washington 98004 USA (888) 512-1195 info@novointegrated.com Disclaimer Privacy Copyright © 2000 - 2021 Novo Integrated Sciences Inc. All rights reserved